Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.

Item
http://www.wikidata.org/entity/Q33427336
Current Management of Primary Immune ThrombocytopeniaBeyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.Successful Percutaneous Nephrolithotomy in Patients with Immune-Mediated Thrombocytopenia Treated with Romiplostim.Pathogenesis and Therapeutic Mechanisms in  Immune Thrombocytopenia (ITP)Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Clinical updates in adult immune thrombocytopenia.A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia.Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain.Remissions after long-term use of romiplostim for immune thrombocytopeniaEfficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.Splenectomy for Immune Thrombocytopenia: Down but not out.Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.
P2860

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.

Item
http://www.wikidata.org/entity/Q33427336
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Remission and platelet respons ...... results from a phase 2 study.
@ast
Remission and platelet respons ...... results from a phase 2 study.
@en
type
label
Remission and platelet respons ...... results from a phase 2 study.
@ast
Remission and platelet respons ...... results from a phase 2 study.
@en
prefLabel
Remission and platelet respons ...... results from a phase 2 study.
@ast
Remission and platelet respons ...... results from a phase 2 study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Remission and platelet respons ...... results from a phase 2 study.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921